|
1
|
Yu X, Wang Q, Zhou X, Fu C, Cheng M, Guo
R, Liu H, Zhang B and Dai M: Celastrol negatively regulates cell
invasion and migration ability of human osteosarcoma via
downregulation of the PI3K/Akt/NF-κB signaling pathway in vitro.
Oncol Lett. 12:3423–3428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cui C and Shi X: miR-187 inhibits tumor
growth and invasion by directly targeting MAPK12 in osteosarcoma.
Exp Ther Med. 14:1045–1050. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang H, Tang M, Ou L, Hou M, Feng T, Huang
YE, Jin Y, Zhang H and Zuo G: Biological analysis of cancer
specific microRNAs on function modeling in osteosarcoma. Sci Rep.
7:53822017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Su YF, Lin CL, Lee KS, Tsai TH, Wu SC,
Hwang SL, Chen SC and Kwan AL: A modified compression model of
spinal cord injury in rats: Functional assessment and the
expression of nitric oxide synthases. Spinal Cord. 53:432–435.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu J, Xiao X, Shen Y, Chen L, Xu C, Zhao
H, Wu Y, Zhang Q, Zhong J, Tang Z, et al: MicroRNA-32 promotes
calcification in vascular smooth muscle cells: Implications as a
novel marker for coronary artery calcification. PLoS One.
12:e01741382017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vishnubalaji R, Hamam R, Yue S, Al-Obeed
O, Kassem M, Liu FF, Aldahmash A and Alajez NM: MicroRNA-320
suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
Oncotarget. 7:35789–35802. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dou L, Lin H, Wang K, Zhu G, Zou X, Chang
E and Zhu Y: Long non-coding RNA CCAT1 modulates neuropathic pain
progression through sponging miR-155. Oncotarget. 8:89949–89957.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu J, Shuang Z, Zhao J, Tang H, Liu P,
Zhang L, Xie X and Xiao X: Linc00152 promotes tumorigenesis by
regulating DNMTs in triple-negative breast cancer. Biomed
Pharmacother. 97:1275–1281. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cui M, Xiao Z, Wang Y, Zheng M, Song T,
Cai X, Sun B, Ye L and Zhang X: Long noncoding RNA HULC modulates
abnormal lipid metabolism in hepatoma cells through an
miR-9-mediated RXRA signaling pathway. Cancer Res. 75:846–857.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu F, Wu L, Wang A, Xu Y, Luo X, Liu X,
Hua Y, Zhang D, Wu S, Lin T, et al: MicroRNA-138 attenuates
epithelial-to-mesenchymal transition by targeting SOX4 in clear
cell renal cell carcinoma. Am J Transl Res. 9:3611–3622.
2017.PubMed/NCBI
|
|
11
|
Zhang F, Liao L, Ju Y, Song A and Liu Y:
Neurochemical plasticity of nitric oxide synthase isoforms in
neurogenic detrusor overactivity after spinal cord injury.
Neurochem Res. 36:1903–1909. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pu Z, Zhang X, Chen Q, Yuan X and Xie H:
Establishment of an expression platform of OATP1B1 388GG and 521CC
genetic polymorphism and the therapeutic effect of tamoxifen in
MCF-7 cells. Oncol Rep. 33:2420–2428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barbie TU, Alexe G, Aref AR, Li S, Zhu Z,
Zhang X, Imamura Y, Thai TC, Huang Y, Bowden M, et al: Targeting an
IKBKE cytokine network impairs triple-negative breast cancer
growth. J Clin Invest. 124:5411–5423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gokal K, Wallis D, Ahmed S, Boiangiu I,
Kancherla K and Munir F: Effects of a self-managed home-based
walking intervention on psychosocial health outcomes for breast
cancer patients receiving chemotherapy: A randomised controlled
trial. Support Care Cancer. 24:1139–1166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kalder M, Kyvernitakis I, Albert US,
Baier-Ebert M and Hadji P: Effects of zoledronic acid versus
placebo on bone mineral density and bone texture analysis assessed
by the trabecular bone score in premenopausal women with breast
cancer treatment-induced bone loss: Results of the ProBONE II
substudy. Osteoporos Int. 26:353–360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chirico A, D'Aiuto G, Penon A, Mallia L,
de Laurentiis M, Lucidi F, Botti G and Giordano A: Self-efficacy
for coping with cancer enhances the effect of reiki treatments
during the Pre-surgery phase of breast cancer patients. Anticancer
Res. 37:3657–3665. 2017.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ren JG, Seth P, Ye H, Guo K, Hanai JI,
Husain Z and Sukhatme VP: Citrate suppresses tumor growth in
multiple models through inhibition of glycolysis, the tricarboxylic
acid cycle and the IGF-1R pathway. Sci Rep. 7:45372017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu H, Dai M, Chen X, Chen X, Qin S and
Dai S: Integrated analysis of the potential roles of miRNAmRNA
networks in triple negative breast cancer. Mol Med Rep.
16:1139–1146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tanaka H, Hazama S, Iida M, Tsunedomi R,
Takenouchi H, Nakajima M, Tokumitsu Y, Kanekiyo S, Shindo Y,
Tomochika S, et al: miR-125b-1 and miR-378a are predictive
biomarkers for the efficacy of vaccine treatment against colorectal
cancer. Cancer Sci. 108:2229–2238. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Murphy JP and Pinto DM: Temporal proteomic
analysis of IGF-1R signalling in MCF-7 breast adenocarcinoma cells.
Proteomics. 10:1847–1860. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kucab JE and Dunn SE: Role of IGF-1R in
mediating breast cancer invasion and metastasis. Breast Dis.
17:41–47. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Heskamp S, van Laarhoven HW,
Molkenboer-Kuenen JD, Franssen GM, Versleijen-Jonkers YM, Oyen WJ,
van der Graaf WT and Boerman OC: ImmunoSPECT and immunoPET of
IGF-1R expression with the radiolabeled antibody R1507 in a
triple-negative breast cancer model. J Nucl Med. 51:1565–1572.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li ZH, Xiong QY, Xu L, Duan P, Yang QO,
Zhou P and Tu JH: miR-29a regulated ER-positive breast cancer cell
growth and invasion and is involved in the insulin signaling
pathway. Oncotarget. 8:32566–32575. 2017.PubMed/NCBI
|
|
25
|
Chen Z, He A, Wang D, Liu Y and Huang W:
Long noncoding RNA HOTTIP as a novel predictor of lymph node
metastasis and survival in human cancer: A systematic review and
meta-analysis. Oncotarget. 8:14126–14132. 2017.PubMed/NCBI
|
|
26
|
Liu C, Liu Z, Li X, Tang X, He J and Lu S:
MicroRNA-1297 contributes to tumor growth of human breast cancer by
targeting PTEN/PI3K/AKT signaling. Oncol Rep. 38:2435–2443. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iskender B, Izgi K, Sakalar C and Canatan
H: Priming hMSCs with a putative anti-cancer compound,
myrtucommulone-a: A way to harness hMSC cytokine expression via
modulating PI3K/Akt pathway? Tumour Biol. 37:1967–1981. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin Y, Deng W, Pang J, Kemper T, Hu J, Yin
J, Zhang J and Lu M: The microRNA-99 family modulates hepatitis B
virus replication by promoting IGF-1R/PI3K/Akt/mTOR/ULK1
signaling-induced autophagy. Cell Microbiol. 19:2017.doi:
10.1111/cmi.12709. View Article : Google Scholar
|
|
29
|
Ma Y, Fu S, Lu L and Wang X: Role of
androgen receptor on cyclic mechanical stretch-regulated
proliferation of C2C12 myoblasts and its upstream signals:
IGF-1-mediated PI3K/Akt and MAPKs pathways. Mol Cell Endocrinol.
450:83–93. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Farr CJ, Easty DJ, Ragoussis J, Collignon
J, Lovell-Badge R and Goodfellow PN: Characterization and mapping
of the human SOX4 gene. Mamm Genome. 4:577–584. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Huo X, Yang XR, He J, Cheng L,
Wang N, Deng X, Jin H, Wang N, Wang C, et al: STAT3-mediated
upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer
metastasis by regulating SOX4. Mol Cancer. 16:1362017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang T, Huan L, Zhang S, Zhou H, Gu L,
Chen X and Zhang L: MicroRNA-212 functions as a tumor-suppressor in
human non-small cell lung cancer by targeting SOX4. Oncol Rep.
38:2243–2250. 2017. View Article : Google Scholar : PubMed/NCBI
|
